Infringement Analysis in Dublin.

A patent infringement analysis Dublin litigators can rely on has to be scoped for how Irish patent disputes are actually run — before the High Court’s fast-track Commercial Court, on a national enforcement track that sits deliberately outside the Unified Patent Court because Ireland has signed but not yet ratified the UPC Agreement. Dublin is the capital of Ireland and the commercial heart of Leinster, home to the European headquarters of Google, Microsoft and Meta, one of the world’s densest pharmaceutical manufacturing clusters, a fast-growing medtech base, and the largest concentration of data centres in Europe. The patents asserted here read on formulations, software, connected devices and hardware systems, and each case turns on evidence that the accused product actually practises the claim. PerspireIP builds the claim charts and evidence-of-use that prove — or defeat — that link.

Where a patent infringement analysis Dublin case is decided

Patent litigation in Ireland runs through a single door. The High Court has exclusive first-instance jurisdiction over patent infringement and revocation actions, and since October 2021 those cases are handled in a dedicated Intellectual Property and Technology List, a specialist sub-list of the High Court’s Commercial Court (the Commercial List) in Dublin. A designated IP judge case-manages each dispute from the close of pleadings, so a patent action that might otherwise take years is typically brought to trial in a number of months. That speed is exactly why Dublin has become a serious European venue for patent disputes.

Admission to the Commercial List brings a mandatory case-management conference where the judge fixes the scope of discovery, expert evidence, and whether the trial should be modular. This proportionality-driven management is the defining feature of the forum, and it rewards a party that arrives with its infringement position already mapped, evidenced and litigation-ready. A first-instance judgment can be appealed to the Court of Appeal, and a further appeal on a point of general public importance lies to the Supreme Court. Because infringement and any validity counterclaim are decided together, the mapping that shows the accused product reads on the claim must be built to withstand cross-examination from day one.

• High Court — Commercial Court, Intellectual Property and Technology List — the fast-track, case-managed first-instance forum for Irish patent infringement and revocation actions
• Court of Appeal — hears appeals from High Court patent judgments
• Supreme Court — the final appellate instance, for points of general public importance
• Intellectual Property Office of Ireland (IPOI) — the national office, renamed from the Patents Office in 2019, that grants the Irish patents being enforced

Ireland and the UPC: signed, not ratified

The single fact that reshapes strategy in Dublin is what does not yet apply. Ireland signed the Unified Patent Court Agreement, but it has not ratified it, because doing so requires amending Article 29 of the Irish Constitution — and that amendment can only be made by a national referendum. A referendum was pencilled in for June 2024, then postponed, and as of 2026 no new date has been set. Until the electorate votes yes, the UPC has no reach in Ireland.

The practical consequence is decisive. There is no Irish local division of the UPC, no Unitary Patent takes effect on Irish soil, and the UPC’s central revocation and pan-European injunction cannot reach an Irish right. A European patent reaches Dublin only as a national Irish patent validated at the IPOI and enforced in the High Court under the Patents Act 1992. Ireland participates in the unitary system politically and has signalled its intention to join once ratification clears, but for now every European patent is litigated here on the national track.

For an infringement analysis this matters enormously. A patentee running a European family cannot fold Ireland into a UPC campaign, and an accused party cannot be swept up by a unitary injunction that reaches Dublin. The Irish front is fought on its own national footing, so the claim chart and evidence-of-use have to be built to Irish procedural standards — for a High Court Commercial List complaint, an interlocutory injunction, and Irish discovery — never for a court that currently has no power in Ireland.

Dublin’s industries and the patents they assert

Dublin’s litigation profile is written by the industries clustered around it. Ireland is one of the world’s largest exporters of pharmaceuticals, and the manufacturing plants of Pfizer, MSD and AbbVie sit within the greater Dublin and Leinster corridor. Pharma is Ireland’s most litigated patent field, and the asserted claims read on formulations, salts and polymorphs, second-medical-use indications, dosage regimens and manufacturing processes. Each one demands that infringement be proven against a specific marketed product or process, not asserted in the abstract, which is why generics-versus-originator battles so often land in the Commercial Court.

The second stream is technology. Dublin hosts the European headquarters of Google, Microsoft and Meta, alongside a deep base of software, semiconductor and platform companies. Their patents cover software-implemented inventions, communications and connected-device systems, where infringement turns on reverse-engineering firmware, protocols and source behaviour. Because so many global players are headquartered here, Ireland is increasingly chosen as a strategic venue in multi-jurisdictional disputes.

A third and fourth stream complete the picture: a mature medtech cluster producing devices, diagnostics and instrumentation, and the largest concentration of data centres in Europe, whose operators sit at the intersection of hardware, cooling, networking and power patents. Whether the technology is a polymorph, a software protocol, a surgical device or a data-centre system, the commercial question is identical: does the accused product or process actually fall within the scope of the asserted claim? Answering it is exactly what an infringement analysis does.

Discovery and search orders: gathering the evidence

Ireland gives a litigant powerful tools to build the very evidence an infringement analysis needs. Irish discovery is broad by European standards: once a case is in the Commercial List, a party can seek disclosure of categories of relevant documents held by the other side, and the case-managing judge fixes the scope at the case-management conference to keep it proportionate. For a patentee that can mean access to manufacturing records, technical specifications and internal design documents that prove how an accused product actually works.

Where evidence risks being destroyed, the High Court can grant an Anton Piller (search) order, allowing inspection and preservation of documents and items on the respondent’s premises. These are exceptional and require a very strong prima facie case, serious potential harm, and clear evidence that the respondent holds incriminating material. Before suit, a Norwich Pharmacal order can compel a third party to disclose the identity of an infringer or the source and distribution network of infringing goods — a route often used to unmask an anonymous online or grey-market seller.

Alongside these, Dublin practitioners rely on interlocutory (preliminary) injunctions under the Campus Oil / American Cyanamid-style balance-of-convenience test, frequently in pharma launch disputes. Every one of these tools is only as strong as the claim mapping behind it: a judge asked to grant a search order or freeze a product launch needs a clear, element-by-element showing of why the accused product reads on the claim. That mapping is the deliverable, and it has to be ready before the application is even filed.

Claim charts and evidence-of-use that win in the High Court

Whether you are asserting a patent or defending against one, the case is won or lost on a single document: the claim chart that maps each element of the asserted claim onto the accused product or process. In a Commercial Court action the case-managing judge expects that mapping to be concrete — tied to the marketed formulation, the software build, the medical device or the data-centre system — and supported by evidence-of-use that stands up to expert cross-examination and any invalidity counterclaim heard in the same trial.

• Element-by-element claim charts mapping every limitation of the asserted claim to the accused product or process
• Evidence-of-use built from product teardowns, laboratory analysis, technical datasheets, regulatory dossiers, source-behaviour and public technical literature
• Doctrine-of-equivalents analysis where the accused product is not a literal match, argued to Irish and EPC standards
• Non-infringement and freedom-to-operate positions for an accused Irish or Ireland-based manufacturer, with claim construction pinned to the prosecution history
• A package scoped to the forum — a High Court Commercial List complaint, an interlocutory-injunction application, or the evidence base for discovery and a search order

The analysis cuts both ways. For a patentee it converts a suspicion into a pleadable infringement case and supports the urgency needed for interim relief. For an accused pharma, software, medtech or data-centre company it builds the non-infringement read that keeps a product on the market and frames the validity defence that runs in the same action. Either way the decisive input is a rigorous, evidence-backed claim chart — not a conclusion asserted without proof.

How PerspireIP builds a Dublin infringement-analysis file

Every engagement follows the same disciplined path. We construct the claim scope first, fixing the correct construction from the claims, specification and prosecution history, then map each element against the real accused product or process. For pharma we work from formulations, polymorph data and regulatory dossiers; for software from firmware, protocols and observed source behaviour; for medtech and data-centre hardware from teardowns and technical datasheets — charting infringement literally and, where needed, under the doctrine of equivalents.

• Claim construction and element-by-element charting to Patents Act 1992 and EPC standards
• Evidence-of-use assembly — teardowns, lab analysis, datasheets, regulatory and public technical sources — dated and documented for Irish discovery
• Infringement and non-infringement positions built for either side of a High Court Commercial List dispute
• Deliverables scoped to your forum: a first-instance complaint, an interlocutory injunction, or the evidence base for a discovery motion or Anton Piller search order
• Coordination with the national, non-UPC enforcement track and, where the family is European, with parallel proceedings abroad

We work alongside your Irish solicitors and counsel as a specialist analysis partner, deliver to High Court Commercial List deadlines, and keep every engagement confidential. Whether you are a pharma, software, medtech or data-centre company enforcing a patent, an accused party clearing a path to market, or litigation counsel preparing a complaint or a defence, we scale to fit — a single claim chart, a multi-patent matter or ongoing portfolio support. Send us the patent number and the accused product, and we will scope a patent infringement analysis Dublin project within one business day.

IP Landscape & Resources in Dublin

Key intellectual-property authorities and venues relevant to Dublin:

• Intellectual Property Office of Ireland (IPOI) — the national office, renamed from the Patents Office in 2019, that grants Irish patents and validates European patents for Ireland
• Courts Service of Ireland — the official body of the Irish courts, including the High Court and its Commercial Court that case-manage patent infringement and revocation actions
• European Patent Office (EPO) — grants the European patents validated nationally in Ireland, which are enforced in the Dublin High Court outside the Unified Patent Court
• Unified Patent Court — the pan-European court that Ireland has signed up to but not yet ratified, so it has no Irish local division and no reach in Ireland pending a constitutional referendum

Request a Patent Infringement Analysis in Dublin

Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.

Frequently Asked Questions